• Infection treatment. microenvironment-to-microorganism-type-specific, low intensity direct current. Effective for bacterial, viral and antibiotic resistant superbug infections.

• Bioelectric healing. Realtime, self adaptive supplementation or replacement of the bioelectric controller of wound healing—the wound-generated electric field; boosts the natural 'current of injury'.

• Accelerated healing. Targeted bio-signaling stimulation of intracellular 'second messenger' molecule pathways: cyclic-A-M-P and cyclic-G-M-P that relay and amplify the messages for metabolic activity and healing.

• Better healing, less scar tissue. Stimulates the self-modification of fibroblast cells in the wound to have tissue regeneration abilities resembling stem cell potentials.

• Reduces pain. Effects on pro-inflammatory mast cells, cross-talk between pain signaling nerve fibers, nociceptor ion channels that detect harmful stimuli, reducing the transmission of pain signals.

• SIS electrodes do not contact wound. No discomfort or disturbance of new granulation and epithelial tissue growth.

• No drug side effects or risks. Quick and easy to apply. For home and in clinic use.

• Artificial Intelligence (AI) machine learning. Repeated electrical stimulation optimization for each individual wound. Device learns how to heal each specific wound and continuously improves its function.

• Australian patented & international application pending device & technology.